Research compound
Tirzepatid
Tirzepatide is a peptide-based compound that activates GIP and GLP-1 receptors.
- Specification
- 30 mg
- Price
- 100,00 €
Research information
What is it?
Tirzepatide is a peptide-based compound that activates GIP and GLP-1 receptors.
Research information
Research focus
Clinical research has examined its effects on satiety, food intake, blood-glucose regulation and body-weight reduction.
PEPTIDE EUROPE / COA
Certificate of analysis
Documentation for the stated sample and batch.
- Laboratory
- Janoshik
- Test date
- 1/19/2026
- Report number
- 99786
- Measured quantity
- 34.18 mg
- Purity
- 99.783%
Edited copy: names and QR codes removed; sample photos omitted where supplied. Test data unchanged.
Verify with laboratory Verification key:
ZFHPDJGANUI8A laboratory report applies to its stated sample and tests. It does not establish clinical safety or efficacy.
View full document ↗Research information only. Not medical advice.

